Retinoid Metabolism and Growth Inhibition in Head and Neck Cancer
Author Information
Author(s): BJM Braakhuis, I Klaassen, BM van der Leede, J Cloos, RH Brakenhoff, MP Copper, T Teerlink, HFJ Hendriks, PT van der Saag, GB Snow
Primary Institution: University Hospital Vrije Universiteit, Amsterdam
Hypothesis
The study investigates the relationship between retinoid metabolism and growth inhibition in head and neck squamous cell carcinoma (HNSCC) cell lines.
Conclusion
The extent of all-trans retinoic acid-induced growth inhibition is proportional to the decrease in retinoid levels in cells and culture medium.
Supporting Evidence
- Retinoids can reverse premalignant lesions in head and neck cancer.
- Acquired resistance to retinoic acid in leukemia is linked to decreased plasma levels.
- Growth inhibition was proportional to the extent of retinoid turnover.
Takeaway
This study found that how much retinoids are used up by cancer cells is linked to how well the cells stop growing.
Methodology
Three HNSCC cell lines were exposed to varying concentrations of all-trans retinoic acid, and growth inhibition was measured using the SRB assay.
Limitations
The study does not address the clinical implications of retinoid metabolism variability among patients.
Want to read the original?
Access the complete publication on the publisher's website